Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions - PubMed (original) (raw)

. 2007 Aug 21;581(21):3961-6.

doi: 10.1016/j.febslet.2007.07.028. Epub 2007 Jul 23.

Affiliations

• PMID: 17662720
• DOI: 10.1016/j.febslet.2007.07.028

Free article

Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions

Shunsuke Ohnishi et al. FEBS Lett. 2007.

Free article

Abstract

Mesenchymal stem cells (MSC) transplantation has been shown to decrease fibrosis in the heart; however, whether MSC directly influence the function of cardiac fibroblasts (CFB) remains unknown. MSC-conditioned medium significantly attenuated proliferation of CFB compared with CFB-conditioned medium. MSC-conditioned medium upregulated antiproliferation-related genes such as elastin, myocardin and DNA-damage inducible transcript 3, whereas CFB-conditioned medium upregulated proliferation-related genes such as alpha-2-macroglobulin and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog. MSC-conditioned medium significantly downregulated type I and III collagen expression, and significantly suppressed type III collagen promoter activity. MSC may exert paracrine anti-fibrotic effects at least in part through regulation of CFB proliferation and collagen synthesis.

PubMed Disclaimer

Similar articles

• Mesenchymal stem cells overexpressing integrin-linked kinase attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions.
  Mao Q, Lin CX, Liang XL, Gao JS, Xu B. Mao Q, et al. Mol Med Rep. 2013 May;7(5):1617-23. doi: 10.3892/mmr.2013.1348. Epub 2013 Feb 28. Mol Med Rep. 2013. PMID: 23450431
• Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells.
  Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, Yagihara T, Kitamura S, Nagaya N. Nakanishi C, et al. Biochem Biophys Res Commun. 2008 Sep 12;374(1):11-6. doi: 10.1016/j.bbrc.2008.06.074. Epub 2008 Jun 27. Biochem Biophys Res Commun. 2008. PMID: 18586003
• Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
  Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Tögel F, et al. Am J Physiol Renal Physiol. 2007 May;292(5):F1626-35. doi: 10.1152/ajprenal.00339.2006. Epub 2007 Jan 9. Am J Physiol Renal Physiol. 2007. PMID: 17213465
• Adult mesenchymal stromal stem cells for therapeutic applications.
  Spitkovsky D, Hescheler J. Spitkovsky D, et al. Minim Invasive Ther Allied Technol. 2008;17(2):79-90. doi: 10.1080/13645700801969758. Minim Invasive Ther Allied Technol. 2008. PMID: 18465443 Review.
• Adverse fibrosis in the aging heart depends on signaling between myeloid and mesenchymal cells; role of inflammatory fibroblasts.
  Cieslik KA, Trial J, Crawford JR, Taffet GE, Entman ML. Cieslik KA, et al. J Mol Cell Cardiol. 2014 May;70:56-63. doi: 10.1016/j.yjmcc.2013.10.017. Epub 2013 Oct 31. J Mol Cell Cardiol. 2014. PMID: 24184998 Free PMC article. Review.

Cited by

• Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.
  Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Djouad F, et al. Nat Rev Rheumatol. 2009 Jul;5(7):392-9. doi: 10.1038/nrrheum.2009.104. Nat Rev Rheumatol. 2009. PMID: 19568253 Review.
• Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.
  Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM. Schuleri KH, et al. Eur Heart J. 2009 Nov;30(22):2722-32. doi: 10.1093/eurheartj/ehp265. Epub 2009 Jul 8. Eur Heart J. 2009. PMID: 19586959 Free PMC article.
• Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.
  Zhang Y, Zhang R, Li Y, He G, Zhang D, Zhang F. Zhang Y, et al. Mol Biol Rep. 2012 Jan;39(1):285-93. doi: 10.1007/s11033-011-0737-y. Epub 2011 May 7. Mol Biol Rep. 2012. PMID: 21553056
• Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
  Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F, Wang B, Balkan W, Rodriguez J, Rosado M, Morales A, Hatzistergos K, Natsumeda M, Margitich I, Schulman IH, Gomes SA, Mushtaq M, DiFede DL, Fishman JE, Pattany P, Zambrano JP, Heldman AW, Hare JM. Karantalis V, et al. J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999. doi: 10.1016/j.jacc.2015.08.879. J Am Coll Cardiol. 2015. PMID: 26516002 Free PMC article.
• Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy.
  Suncion VY, Schulman IH, Hare JM. Suncion VY, et al. Stem Cells Transl Med. 2012 Jan;1(1):29-35. doi: 10.5966/sctm.2011-0014. Epub 2011 Dec 7. Stem Cells Transl Med. 2012. PMID: 23197637 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal